Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mehnaz I Ferdousi"'
Autor:
Mehnaz I. Ferdousi, Patricia Calcagno, Connie Sanchez, Karen L. Smith, John P. Kelly, Michelle Roche, David P. Finn
Publikováno v:
Frontiers in Pain Research, Vol 4 (2023)
IntroductionChronic pain is often associated with comorbid anxiety and cognitive dysfunction, negatively affecting therapeutic outcomes. The influence of genetic background on such interactions is poorly understood. The stress-hyperresponsive Wistar
Externí odkaz:
https://doaj.org/article/10e5361d06f441ba8957d01cacccae79
Publikováno v:
Biomedicines, Vol 9, Iss 6, p 610 (2021)
Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors that exist in three isoforms: PPARα, PPARβ/δ and PPARγ. Studies suggest that the PPAR signalling system may modulate pain, anxiety and cognition. The a
Externí odkaz:
https://doaj.org/article/aaaf85c6dd284c9ea4fbaa73163adbd1
Autor:
John P. Kelly, Karen Smith, Morgane Clarke, Michelle Roche, Connie Sanchez, David J. Eyerman, David P. Finn, Sonali Aggarwal, Patricia Calcagno, Mehnaz I Ferdousi
Publikováno v:
Pain. 162:405-420
Chronic pain is often comorbid with anxiety and depression, altering the level of perceived pain, which negatively affects therapeutic outcomes. The role of the endogenous mu-opioid receptor (MOP) system in pain-negative affect interactions and the i
Autor:
Nikita N. Burke, Daniel R. Deaver, David P. Finn, Michelle Roche, John P. Kelly, Mehnaz I Ferdousi
Publikováno v:
Neuropharmacology. 146:327-336
Modulation of the opioid system has re-emerged as a potential therapeutic avenue for treating depression, with efficacy of a fixed-dose combination of buprenorphine (BUP), a partial mu-opioid receptor (MOR) agonist and kappa-opioid receptor (KOR) ant
Autor:
Jing Liao, Daniel Segelcke, Xue Ying Zhang, Amber L. Harris Bozer, Andrew S.C. Rice, Elliot J. Krane, Darragh Mattimoe, Simon Hong, Christopher Sena, Malcolm R. Macleod, Daniel P McLoone, Harutyun Alaverdyan, Esther M. Pogatzki-Zahn, Alexander Davidson, Amelia K Mardon, James Thomas, Simon Haroutounian, Catherine B. Healy, Jingwen Zhang, Ahmed Barakat, Rafael Vinagre, Andrea G. Hohmann, Emer Power, Eleny Romanos-Sirakis, Bruno Pradier, Jan Vollert, Arul James, Tyler Barthlow, Hayley B. Leake, Julio A. Yanes, Michael Mansfield, Mary Hopkins, Mehnaz I Ferdousi, David P. Finn, Nathalie M. Malewicz, Astra Segelcke, Nadia Soliman, Antonina Dolgorukova, Gith Noes-Holt, Marta Diaz-delCastillo, Kimberley E. Wever
Publikováno v:
Pain, 162, S26-s44
Pain, 162, Suppl 1, pp. S26-s44
Pain
Pain, 162, Suppl 1, pp. S26-s44
Pain
Supplemental Digital Content is Available in the Text.
We report a systematic review and meta-analysis of studies that assessed the antinociceptive efficacy of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators on pain
We report a systematic review and meta-analysis of studies that assessed the antinociceptive efficacy of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators on pain
Publikováno v:
Biomedicines
Volume 9
Issue 6
Biomedicines, Vol 9, Iss 610, p 610 (2021)
Volume 9
Issue 6
Biomedicines, Vol 9, Iss 610, p 610 (2021)
Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors that exist in three isoforms: PPAR¿, PPARß/¿ and PPAR¿. Studies suggest that the PPAR signalling system may modulate pain, anxiety and cognition. The a
Autor:
Mehnaz I Ferdousi, David P. Finn
Depending on its nature, duration, and intensity, stress can exert potent and bidirectional modulatory effects on pain, either reducing pain (stress-induced analgesia) or exacerbating it (stress-induced hyperalgesia). The descending pain pathway has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::032a7b27497a5850dc3a9d2e647ca57e
https://doi.org/10.1016/bs.pbr.2018.07.002
https://doi.org/10.1016/bs.pbr.2018.07.002
Autor:
David P. Finn, Mehnaz I Ferdousi, Patricia Calcagno, Michelle Roche, P. Calcagno, Connie Sanchez, John P. Kelly, K. McHugh
Publikováno v:
European Neuropsychopharmacology. 29:S105
This abstract is financially supported by an educational grant from the Strategic Partnership Programme Grant from Science Foundation Ireland and Alkermes, Inc. (14/SPP/B3051).